Literature DB >> 28176181

Transthoracic contrast echocardiography using vitamin B6 and sodium bicarbonate as contrast agents for the diagnosis of patent foramen ovale.

Jiang-Chun He1, Jian-Yong Zheng1, Xin Li2, Ye Yang1, Bo-Yang Zhang1, Yu Chen1, Xian-Feng Li1, Ying-Ming Liu1, Yi Cao1, Li Zhao1, Tian-Chang Li3.   

Abstract

To evaluate the utility of transthoracic contrast echocardiography (cTTE) using vitamin B6 and sodium bicarbonate as contrast agents for diagnosing right-to-left shunt (RLS) caused by patent foramen ovale (PFO) compared to that of transesophageal echocardiography (TEE). We investigated 125 patients admitted to our neurology department with unexplained cerebral infarction and migraine. All patients underwent cTTE using vitamin B6 and sodium bicarbonate as contrast agents, after which they underwent transthoracic echocardiography. The Doppler signal was recorded during the Valsalva maneuver, and TEE examinations were performed. The feasibility, diagnostic sensitivity, and safety of cTTE and TEE for PFO recognition were compared. Evidence of PFO was found in 49 (39.20%) patients with cTTE, more than were detected with TEE (39, 31.20%) (χ2=5.0625, P=0.0244). cTTE had a sensitivity of 92.31% and a specificity of 84.88% for diagnosing PFO, showing high concordance with TEE for PFO recognition (κ=0.72). Further, results of a semi-quantitative evaluation of PFO-RLS by cTTE were better than those with TEE (Z=-2.011, P=0.044). No significant adverse reaction was discovered during cTTE examination. cTTE using vitamin B6 and sodium bicarbonate as contrast agents has relatively good sensitivity and specificity for diagnosing RLS caused by PFO when compared with those for TEE. Using vitamin B6 and sodium bicarbonate as contrast agents to perform cTTE is recommended for detecting and diagnosing the PFO due to its simplicity, non-invasive character, low cost, and high feasibility.

Entities:  

Keywords:  Patent foramen ovale; Sodium bicarbonate; Transesophageal echocardiography; Transthoracic contrast echocardiography; Vitamin B6

Mesh:

Substances:

Year:  2017        PMID: 28176181     DOI: 10.1007/s10554-017-1088-0

Source DB:  PubMed          Journal:  Int J Cardiovasc Imaging        ISSN: 1569-5794            Impact factor:   2.357


  24 in total

1.  The International classification of headache disorders, 2nd edn (ICDH-II).

Authors:  J Olesen; T J Steiner
Journal:  J Neurol Neurosurg Psychiatry       Date:  2004-06       Impact factor: 10.154

2.  Transthoracic echocardiography using second harmonic imaging with Valsalva manoeuvre for the detection of right to left shunts.

Authors:  N R A Clarke; J Timperley; A D Kelion; A P Banning
Journal:  Eur J Echocardiogr       Date:  2004-06

3.  Second harmonic transthoracic echocardiography: the new reference screening method for the detection of patent foramen ovale.

Authors:  Cathy Daniëls; Caroline Weytjens; Bernard Cosyns; Danny Schoors; Johan De Sutter; Bernard Paelinck; Luc Muyldermans; Guy Van Camp
Journal:  Eur J Echocardiogr       Date:  2004-12

4.  Diagnosis and quantification of patent foramen ovale. Which is the reference technique? Simultaneous study with transcranial Doppler, transthoracic and transesophageal echocardiography.

Authors:  Teresa González-Alujas; Artur Evangelista; Estevo Santamarina; Marta Rubiera; Zamira Gómez-Bosch; José F Rodríguez-Palomares; Gustavo Avegliano; Carlos Molina; José Alvarez-Sabín; David García-Dorado
Journal:  Rev Esp Cardiol       Date:  2011-02       Impact factor: 4.753

5.  Effect of initial gas bubble composition on detection of inducible intrapulmonary arteriovenous shunt during exercise in normoxia, hypoxia, or hyperoxia.

Authors:  Jonathan E Elliott; Yujung Choi; Steven S Laurie; Ximeng Yang; Igor M Gladstone; Andrew T Lovering
Journal:  J Appl Physiol (1985)       Date:  2010-09-16

6.  Contrast transcranial Doppler can diagnose large patent foramen ovale.

Authors:  Kazuto Kobayashi; Yasuyuki Iguchi; Kazumi Kimura; Yoko Okada; Yuka Terasawa; Noriko Matsumoto; Kenichirou Sakai; Jyunya Aoki; Kensaku Shibazaki
Journal:  Cerebrovasc Dis       Date:  2009-01-29       Impact factor: 2.762

7.  Comparison of medical treatment with percutaneous closure of patent foramen ovale in patients with cryptogenic stroke.

Authors:  Stephan Windecker; Andreas Wahl; Krassen Nedeltchev; Marcel Arnold; Markus Schwerzmann; Christian Seiler; Heinrich P Mattle; Bernhard Meier
Journal:  J Am Coll Cardiol       Date:  2004-08-18       Impact factor: 24.094

8.  Cerebral infarction and migraine: clinical and radiologic correlations.

Authors:  L J Dorfman; W H Marshall; D R Enzmann
Journal:  Neurology       Date:  1979-03       Impact factor: 9.910

Review 9.  Patent foramen ovale: the current state of play.

Authors:  Kaleab N Asrress; Maciej Marciniak; Anna Marciniak; Ronak Rajani; Brian Clapp
Journal:  Heart       Date:  2015-10-20       Impact factor: 5.994

10.  Transcranial Doppler ultrasonography should it be the first choice for persistent foramen ovale screening?

Authors:  Monika Komar; Maria Olszowska; Tadeusz Przewłocki; Jakub Podolec; Jakub Stępniewski; Bartosz Sobień; Rafał Badacz; Anna Kabłak-Ziembicka; Lidia Tomkiewicz-Pająk; Piotr Podolec
Journal:  Cardiovasc Ultrasound       Date:  2014-05-22       Impact factor: 2.062

View more
  3 in total

1.  Cardiovascular imaging 2017 in the International Journal of Cardiovascular Imaging.

Authors:  Johan H C Reiber; Amer Alaiti; Hiram G Bezerra; Johan De Sutter; Paul Schoenhagen; Arthur E Stillman; Nico R L Van de Veire
Journal:  Int J Cardiovasc Imaging       Date:  2018-06       Impact factor: 2.357

2.  A comparison of contrast transthoracic echocardiography and contrast transcranial Doppler in cryptogenic stroke patients with patent foramen ovale.

Authors:  Jie Chen; Luyun Chen; Wangwang Hu; Xianda Ni; Zengrui Zhang; Xiaowen Feng; Zijian Fan; Cuiping Chen; Fengzhen Qiu; Bei Shao
Journal:  Brain Behav       Date:  2019-04-02       Impact factor: 2.708

3.  Comparison of Different Contrast Agents in Detecting Cardiac Right-to-Left Shunt in Patients with a Patent Foramen Ovale during Contrast-Transthoracic Echocardiography.

Authors:  Enfa Zhao; Gesheng Cheng; Yushun Zhang; Yang Li; Yingli Wang
Journal:  Biomed Res Int       Date:  2017-12-03       Impact factor: 3.411

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.